Pharmaceutical Care and Literature Review of Rivaroxaban in the Treatment of Low-Weight Patient with Chronic Thromboembolic Pulmonary Hypertension by Clinical Pharmacists

LI Jiale; WANG Xiaoxing; KONG Xudong; QIN Wangjun; ZHAO Li

doi:10.14009/j.issn.1672-2124.2020.04.025

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical Care and Literature Review of Rivaroxaban in the Treatment of Low-Weight Patient with Chronic Thromboembolic Pulmonary Hypertension by Clinical Pharmacists

更新时间：2022-10-08

- Pharmaceutical Care and Literature Review of Rivaroxaban in the Treatment of Low-Weight Patient with Chronic Thromboembolic Pulmonary Hypertension by Clinical Pharmacists
- Vol. 20, Issue 4, Pages: 480-483(2020)
- 作者机构：
  
  1. 广州市妇女儿童医疗中心药学部
  2. 中日友好医院药学部
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.04.025
  CLC： R544.1
- Published：2020，
扫描看全文
[1]李佳乐,王晓星,孔旭东,覃旺军,赵莉.临床药师对低体质量慢性血栓栓塞性肺动脉高压患者应用利伐沙班的药学监护及文献复习[J].中国医院用药评价与分析,2020,20(04):480-483.

LI Jiale, WANG Xiaoxing, KONG Xudong, et al. Pharmaceutical Care and Literature Review of Rivaroxaban in the Treatment of Low-Weight Patient with Chronic Thromboembolic Pulmonary Hypertension by Clinical Pharmacists. [J]. 20(4):480-483(2020)
[1]李佳乐,王晓星,孔旭东,覃旺军,赵莉.临床药师对低体质量慢性血栓栓塞性肺动脉高压患者应用利伐沙班的药学监护及文献复习[J].中国医院用药评价与分析,2020,20(04):480-483. DOI： 10.14009/j.issn.1672-2124.2020.04.025.

LI Jiale, WANG Xiaoxing, KONG Xudong, et al. Pharmaceutical Care and Literature Review of Rivaroxaban in the Treatment of Low-Weight Patient with Chronic Thromboembolic Pulmonary Hypertension by Clinical Pharmacists. [J]. 20(4):480-483(2020) DOI： 10.14009/j.issn.1672-2124.2020.04.025.

摘要

目的:探讨低体质量慢性血栓栓塞性肺动脉高压患者服用利伐沙班后凝血异常的原因及剂量选择。方法:临床药师深入临床

对1例低体质量慢性血栓栓塞性肺动脉高压患者实施药学监护。临床药师计算机检索各数据库

结合相关文献

分析患者出现凝血异常的原因

评定患者使用利伐沙班的剂量

提出个体化给药建议。结果与结论:极端体质量患者使用常规剂量的利伐沙班

凝血酶原时间变化有一定的意义

必要时进行血药浓度监测是最佳选择。

Abstract

OBJECTIVE: To probe into the causes and dosage selection of coagulation abnormalities after rivaroxaban administration in low-weight patients with chronic thromboembolic pulmonary hypertension. METHODS:Clinical pharmacists performed pharmaceutical care for the low-weight patients with chronic thromboembolic pulmonary hypertension

searched each database by computer

analyzed the causes of coagulation abnormalities in patients combined with relevant literature

assessed the dose of rivaroxaban used by patients

and proposed individualized drug administration suggestions. RESULTS & CONCLUSIONS: In patients with extreme body weight

the conventional dose of rivaroxaban can be used. The change in prothrombin time is of some significance. And the monitoring of the blood concentration when necessary is the best choice.

关键词

血栓栓塞性肺动脉高压低体质量利伐沙班凝血指标血药浓度

Keywords

Thromboembolic pulmonary hypertensionLow body weightRivaroxabanCoagulation indexBlood concentration

references

查看原文

Views

101

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmacodynamic Analysis of Levetiracetam in the Treatment of Epilepsy in Children

Intervention of Huangqi Guizhi Wuwu Decoction in Rats with Blood Stasis Syndrome Based on Liquid Chromatography-Quadrupole-Time of Flight-Mass Spectrometry Blood Metabolomics

Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis

Research on the Value of Blood Concentration and Gene Detection of Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia

Related Author

LI Xingang

LU Wei

WEI Minji

WU Ye

WANG Li

WANG Yinghui

WANG Tao

CAI Xiaojun

Related Institution

Peking University School of Pharmaceutical Sciences

Dept.of Pediatric, Peking University First Hospital

Dept.of Pediatric, Beijing Friendship Hospital, Capital Medical University

Dept.of Gastroenterology,Xiangyang Hospital of Traditional Chinese Medicine

Dept.of Endocrinology,Heilongjiang Academy of Traditional Chinese Medicine

⁰